Today, CryoLife's short interest was reported at about 464m for the period ending August 14, 2009, down from approximately 577m at the end of July. August 15, 2008, the short interest was reported at exactly 1,706,752 shares sold short, so, roughly speaking, the amount of shares sold short has gone down about 75% in the past twelve months. Most of the time, not always, but most of the time the professionals are correct when it comes to the rate of short selling in a security. Perhaps, nothing of substance will come out in the news, however, right now, one can only think that there should be some positive reason for what is going on with trading volume, short interest, etc. Anderson, the chairman of CRY, did say in the webcast on July 30 that they expected final IDE approval with FDA for BioFoam by the end of August. It doesn't sound very momentous to me, but that's five days from now.
CRY will bubble up on a short squeeze that will come sooner or later. The astute investors are already covered and long. I'm short nothing at this point only long. The under performers and the always wrong depressed individuals are the only ones short this market.